Atossa Therapeutics, Inc. (ATOS)
2.63
-0.02
(-0.75%)
USD |
NASDAQ |
Aug 27, 16:00
2.63
0.00 (0.00%)
After-Hours: 20:00
Atossa Therapeutics Shareholders Equity (Quarterly) : 26.83M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 26.83M |
| March 31, 2026 | 30.49M |
| December 31, 2025 | 39.35M |
| September 30, 2025 | 49.79M |
| June 30, 2025 | 57.70M |
| March 31, 2025 | 65.32M |
| December 31, 2024 | 71.48M |
| September 30, 2024 | 73.68M |
| June 30, 2024 | 80.16M |
| March 31, 2024 | 85.76M |
| December 31, 2023 | 91.02M |
| September 30, 2023 | 98.25M |
| June 30, 2023 | 104.88M |
| March 31, 2023 | 113.26M |
| December 31, 2022 | 117.96M |
| September 30, 2022 | 123.86M |
| June 30, 2022 | 130.26M |
| March 31, 2022 | 135.16M |
| December 31, 2021 | 138.14M |
| September 30, 2021 | 141.35M |
| June 30, 2021 | 144.07M |
| March 31, 2021 | 139.70M |
| December 31, 2020 | 27.17M |
| September 30, 2020 | 9.871M |
| June 30, 2020 | 8.374M |
| Date | Value |
|---|---|
| March 31, 2020 | 10.90M |
| December 31, 2019 | 13.16M |
| September 30, 2019 | 15.02M |
| June 30, 2019 | 17.55M |
| March 31, 2019 | 19.50M |
| December 31, 2018 | 8.805M |
| September 30, 2018 | 10.57M |
| June 30, 2018 | 13.57M |
| March 31, 2018 | 5.260M |
| December 31, 2017 | 6.939M |
| September 30, 2017 | 2.563M |
| June 30, 2017 | 2.804M |
| March 31, 2017 | 1.528M |
| December 31, 2016 | 3.097M |
| September 30, 2016 | 5.414M |
| June 30, 2016 | 2.410M |
| March 31, 2016 | 3.773M |
| December 31, 2015 | |
| September 30, 2015 | 9.059M |
| June 30, 2015 | 13.12M |
| March 31, 2015 | 10.28M |
| December 31, 2014 | 9.498M |
| September 30, 2014 | 15.23M |
| June 30, 2014 | 18.26M |
| March 31, 2014 | 21.30M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Immix Biopharma, Inc. | 228.92M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 32.28M |
| Total Liabilities (Quarterly) | 5.451M |
| Current Ratio | 5.689 |